Short, full-dose adjuvant chemotherapy (CT) in high-risk adult soft tissue sarcomas (STS): long-term follow-up of a randomized clinical trial from the Italian Sarcoma Group and the Spanish Sarcoma GroupAlessandro Gronchi, Piero Picci, Antonino De Paoli et al.|Annals of Oncology|2016Cited by 132
Dacarbazine in Solitary Fibrous Tumor: A Case Series Analysis and Preclinical Evidence vis-à-vis Temozolomide and AntiangiogenicsSilvia Stacchiotti, Paolo G. Casali, M. Tortoreto et al.|Clinical Cancer Research|2013Cited by 80
A feasibility study of preoperative pembrolizumab before radical nephroureterectomy in patients with high-risk, upper tract urothelial carcinoma: PURE-02Andrea Necchi, Francesco Montorsi, Alberto Martini et al.|Urologic Oncology Seminars and Original Investigations|2021Cited by 42
Neoadjuvant Chemotherapy VI-RADS Scores for Assessing Muscle-invasive Bladder Cancer Response to Neoadjuvant Immunotherapy with Multiparametric MRIGiorgio Brembilla, Francesco De Cobelli, Giuseppe Basile et al.|Radiology|2024Cited by 31
Eleven-year Management of Prostate Cancer Patients on Active Surveillance: What have We Learned?C. Marenghi, R. Valdagni, M.F. Alvisi et al.|Tumori Journal|2017Cited by 25